Chemotherapy-Induced Nausea And Vomiting (CINV) Global Market Size, Trends Forecast, Strategies By 2032

The Business Research Company’s Chemotherapy-Induced Nausea And Vomiting (CINV) Global Market Report 2024is the most detailed report available on the market, including broad forecast periods and multiple geographies. The reportcovers the historic period – 2010-2021, and the forecast period – 2023-2032. The Chemotherapy-Induced Nausea And Vomiting (CINV) Global Market Report 2023evaluates chemotherapy-induced nausea and vomiting (cinv) market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Request AFree Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13031&type=smp

The global chemotherapy-induced nausea and vomiting (cinv) market is expected to grow from$2.69 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in chemotherapy use, improved antiemetic agents, clinical guidelines, patient advocacy.The chemotherapy-induced nausea and vomiting (cinv) market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.

The increasing prevalence of cancer is expected to propel the growth of chemotherapy-induced nausea and vomiting (CINV) market going forward. Cancer is when some cells in the body develop uncontrolled and spread to other body regions. As cancer cases continue to grow, there is a greater incentive to develop more effective and targeted anti-emetic treatments to alleviate CINV, a distressing side effect of chemotherapy. This heightened focus on CINV management has led to advancements in understanding its underlying mechanisms and developing novel therapies. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based volunteer health organization committed to cancer eradication, in the United States, it is anticipated to be 1.9 million new cancer cases (approximately 5,370 cases per day) and 609,820 cancer deaths (about 1,670 deaths per day) in 2023. Therefore, the increasing prevalence of cancer will drive the chemotherapy-induced nausea and vomiting (CINV) market.

 

Get More Information On The Chemotherapy-Induced Nausea And Vomiting (CINV) Market Report:

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

The chemotherapy-induced nausea and vomiting (cinv) market segments in the report are:

1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications

The table of contents in TBRC’s chemotherapy-induced nausea and vomiting (cinv) market report includes:
1. Executive Summary
2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Characteristics
3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends And Strategies
4. Chemotherapy-Induced Nausea and Vomiting (CINV) Market – Macro Economic Scenario
5. Impact Of High Inflation On Market
…………………….
32. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Benchmarking
33. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Chemotherapy-Induced Nausea and Vomiting (CINV) Market
35. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Future Outlook and Potential Analysis
36. Appendix

 

 

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn:https://in.linkedin.com/company/the-business-research-company

Twitter:https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog:https://blog.tbrc.info/

Healthcare Blog:https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model